SEC Form 4 · accession 0000899243-15-009230
Aegerion Pharmaceuticals, Inc. · AEGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Scheer
Director
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001338042
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 1, 2015 | J | 1,855 | $0.00 | D | 585,364 | I | See Footnote |
| Common StockF1 | Dec 1, 2015 | J | 64,014 | $0.00 | D | 521,350 | I | See Footnote |
| Common Stock | holding | — | — | — | 10,000 | D | ||
| Common StockF1 | holding | — | — | — | 587,219 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares held by Scheer Investment Holdings VII, LLC. The Reporting Person, David Scheer, is the managing member of Scheer Investment Holdings VII, LLC. Mr. Scheer disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
- F2Distribution by Scheer Investment Holdings VII, LLC to current and former employees.